[TP53B]

Y Qin1, J Xie1, Y Q Wang1

  • 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen518116, China.

Zhonghua yi xue za zhi
|December 18, 2024
PubMed
概括

患有TP53突变扩散大B细胞淋巴瘤 (DLBCL) 的晚期或升高的LDH患者的预后较差. BCL2放大也表明结果更差,但组合治疗可能会改善早期DLBCL预后.